Published in Ann Intern Med on October 06, 2009
2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation (2013) 10.24
2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2013) 8.90
Practical use of the Framingham risk score in primary prevention: Canadian perspective. Can Fam Physician (2011) 2.27
Understanding the somatic consequences of depression: biological mechanisms and the role of depression symptom profile. BMC Med (2013) 1.78
Assessing the role of circulating, genetic, and imaging biomarkers in cardiovascular risk prediction. Circulation (2011) 1.77
Chronic inflammation in FMF: markers, risk factors, outcomes and therapy. Nat Rev Rheumatol (2010) 1.45
The association between plasma 25-hydroxyvitamin D3 concentrations, C-reactive protein levels, and coronary artery atherosclerosis in postmenopausal monkeys. Menopause (2012) 1.40
Understanding how we age: insights into inflammaging. Longev Healthspan (2013) 1.22
C-reactive protein and prediction of 1-year mortality in prevalent hemodialysis patients. Clin J Am Soc Nephrol (2011) 1.21
Discordant risk: overweight and cardiometabolic risk in Chinese adults. Obesity (Silver Spring) (2013) 1.09
Troponin T, B-type natriuretic peptide, C-reactive protein, and cause-specific mortality. Ann Epidemiol (2012) 1.04
Periodontal disease as a risk marker in coronary heart disease and chronic kidney disease. Curr Opin Nephrol Hypertens (2010) 1.01
Analysis of biomarker data: logs, odds ratios, and receiver operating characteristic curves. Curr Opin HIV AIDS (2010) 1.01
C-reactive protein, bone strength, and nine-year fracture risk: data from the Study of Women's Health Across the Nation (SWAN). J Bone Miner Res (2013) 0.98
Intraindividual variability of C-reactive protein: the Multi-Ethnic Study of Atherosclerosis. Atherosclerosis (2012) 0.97
Interaction of inflammation, hyperuricemia, and the prevalence of hypertension among adults free of metabolic syndrome: NHANES 2009-2010. J Am Heart Assoc (2014) 0.94
C-reactive protein concentration predicts mortality in type 2 diabetes: the Diabetes Heart Study. Diabet Med (2012) 0.93
Association between use of specialty dietary supplements and C-reactive protein concentrations. Am J Epidemiol (2012) 0.93
Association of cardiovascular burden with mobility limitation among elderly people: a population-based study. PLoS One (2013) 0.92
The combination of abdominal obesity and high-sensitivity C-reactive protein predicts new-onset hypertension in the general Japanese population: the Tanno-Sobetsu study. Hypertens Res (2015) 0.91
Household income and cardiovascular disease risks in U.S. children and young adults: analyses from NHANES 1999-2008. Diabetes Care (2011) 0.90
Biomarkers and cardiovascular risk assessment for primary prevention: an update. Clin Chem (2011) 0.89
Intensive glucose lowering and cardiovascular disease prevention in diabetes: reconciling the recent clinical trial data. Circulation (2010) 0.89
Should C-reactive protein be a target of therapy? Diabetes Care (2011) 0.88
Modern risk stratification in coronary heart disease. J Med Life (2011) 0.88
Relation of uric acid to serum levels of high-sensitivity C-reactive protein, triglycerides, and high-density lipoprotein cholesterol and to hepatic steatosis. Am J Cardiol (2012) 0.87
Biomarkers and HIV-associated cardiovascular disease. Curr Opin HIV AIDS (2010) 0.87
Associations between markers of inflammation and physiological and pharmacological levels of circulating sex hormones in postmenopausal women. Menopause (2010) 0.87
Effects of Olive Oil on Markers of Inflammation and Endothelial Function-A Systematic Review and Meta-Analysis. Nutrients (2015) 0.86
Toward clinically applicable biomarkers in bipolar disorder: focus on BDNF, inflammatory markers, and endothelial function. Curr Psychiatry Rep (2013) 0.86
Impaired retinal vasodilator responses in prediabetes and type 2 diabetes. Acta Ophthalmol (2013) 0.86
C-reactive protein and cardiovascular disease in East asians: a systematic review. Clin Med Insights Cardiol (2015) 0.86
White Blood Cells, Neutrophils, and Reactive Oxygen Metabolites among Asymptomatic Subjects. Int J Prev Med (2012) 0.85
AGE-Related Differences of Novel Atherosclerotic Risk Factors and Angiographic Profile Among Gujarati Acute Coronary Syndrome Patients. J Clin Diagn Res (2015) 0.85
Accumulation and expression of serum amyloid P component in human atherosclerotic lesions. Atherosclerosis (2010) 0.85
Soy and Health Update: Evaluation of the Clinical and Epidemiologic Literature. Nutrients (2016) 0.85
Six-year change in high-sensitivity C-reactive protein and risk of diabetes, cardiovascular disease, and mortality. Am Heart J (2015) 0.84
Leukocyte Telomere Length in Relation to 17 Biomarkers of Cardiovascular Disease Risk: A Cross-Sectional Study of US Adults. PLoS Med (2016) 0.84
Relation of resistin levels with C-reactve protein, homocysteine and uric acid in smokers and non-smokers. J Res Med Sci (2011) 0.83
C-reactive protein and coronary heart disease: all said--is not it? Mediators Inflamm (2014) 0.83
Clinical utility of novel biomarkers in the prediction of coronary heart disease. Korean Circ J (2012) 0.83
Inflammatory cytokines as predictive markers for early detection and progression of diabetic nephropathy. EPMA J (2010) 0.83
C-reactive protein, bone loss, fracture, and mortality in elderly women: a longitudinal study in the OPRA cohort. Osteoporos Int (2014) 0.82
Improvement of blood inflammatory marker levels in patients with hypothyroidism under levothyroxine treatment. BMC Endocr Disord (2015) 0.82
Electrical detection of C-reactive protein using a single free-standing, thermally controlled piezoresistive microcantilever for highly reproducible and accurate measurements. Sensors (Basel) (2013) 0.82
Significant association between serum interleukin-6 and Helicobacter pylori antibody levels among H. pylori-positive Japanese adults. Mediators Inflamm (2013) 0.81
Are C-reactive protein associated genetic variants associated with serum levels and retinal markers of microvascular pathology in Asian populations from Singapore? PLoS One (2013) 0.81
Association of NT-proBNP and multiple biomarkers with severity of angiographic coronary artery disease in diabetic and pre-diabetic Chinese patients. PLoS One (2011) 0.81
High-sensitivity C-reactive protein is not a risk factor for venous thromboembolism: the Tromso study. Haematologica (2011) 0.81
The contribution of a 9p21.3 variant, a KIF6 variant, and C-reactive protein to predicting risk of myocardial infarction in a prospective study. BMC Cardiovasc Disord (2011) 0.81
Metabolic biomarkers for predicting cardiovascular disease. Vasc Health Risk Manag (2013) 0.81
Drug therapies for the primary prevention of cardiovascular events: trials and errors: 2009 Ancel Keys Memorial Lecture. Circulation (2010) 0.81
Oral postmenopausal hormone therapy, C-reactive protein, and cardiovascular outcomes. Menopause (2011) 0.80
Peripheral Endothelial (Dys)Function, Arterial Stiffness and Carotid Intima-Media Thickness in Patients after Kawasaki Disease: A Systematic Review and Meta-Analyses. PLoS One (2015) 0.80
C-reactive protein is an independent predictor for 1-year mortality in elderly patients undergoing hip fracture surgery: A retrospective analysis. Medicine (Baltimore) (2016) 0.79
Weight and metabolic effects of dietary weight loss and exercise interventions in postmenopausal antidepressant medication users and non-users: a randomized controlled trial. Prev Med (2013) 0.79
Favorable Levels of All Major Cardiovascular Risk Factors at Younger Ages and High-Sensitivity C-Reactive Protein 39 Years Later -The Chicago Healthy Aging Study. Prev Med Rep (2015) 0.78
Circulating, imaging, and genetic biomarkers in cardiovascular risk prediction. Trends Cardiovasc Med (2011) 0.78
Ethnic differences in cardiometabolic risk profile at age 5-6 years: the ABCD study. PLoS One (2012) 0.78
The case for C-reactive protein as a risk marker for coronary heart disease. Ann Intern Med (2010) 0.78
Functional measures, inflammatory markers and endothelin-1 as predictors of 360-day survival in centenarians. Age (Dordr) (2015) 0.78
Inflammatory/hemostatic biomarkers and coronary artery calcification in midlife women of African-American and White race/ethnicity: the Study of Women's Health Across the Nation (SWAN) heart study. Menopause (2016) 0.78
Insulin resistance and systemic inflammation, but not metabolic syndrome phenotype, predict 9 years mortality in older adults. Atherosclerosis (2014) 0.78
Dan-Shen-Yin protects the heart against inflammation and oxidative stress induced by acute ischemic myocardial injury in rats. Exp Ther Med (2011) 0.78
Cardiometabolic risk in a population of older adults with multiple co-morbidities in rural south africa: the HAALSI (Health and Aging in Africa: longitudinal studies of INDEPTH communities) study. BMC Public Health (2017) 0.78
The interleukin-1 cluster, dyslipidaemia and risk of myocardial infarction. BMC Med (2010) 0.77
Relation of resistın wıth obesity and some cardiovascular risk factors in hypertensive women. J Res Med Sci (2012) 0.77
Sex differences in the impact of the Mediterranean diet on systemic inflammation. Nutr J (2015) 0.77
Effect of increased leptin and C-reactive protein levels on mortality: results from the National Health and Nutrition Examination Survey. Atherosclerosis (2014) 0.77
Neutrophil to Lymphocyte Ratio and Cardiovascular Disease Incidence in HIV-Infected Patients: A Population-Based Cohort Study. PLoS One (2016) 0.77
Fcγ receptors and ligands and cardiovascular disease. Circ Res (2015) 0.77
Screening strategies for cardiovascular disease in asymptomatic adults. Prim Care (2014) 0.76
Effects of lifestyle measures, antiobesity agents, and bariatric surgery on serological markers of inflammation in obese patients. Mediators Inflamm (2010) 0.76
Predictors of Atherosclerosis in Ankylosing Spondylitis. Rheumatol Ther (2015) 0.76
Measured Pulmonary and Systemic Markers of Inflammation and Oxidative Stress Following Wildland Firefighter Simulations. J Occup Environ Med (2016) 0.76
Update on the NCEP ATP-III emerging cardiometabolic risk factors. BMC Med (2014) 0.76
Is inflammatory chronic obstructive pulmonary disease a coronary heart disease risk equivalent? A longitudinal analysis of the third National Health and Nutrition Examination Survey (NHANES III), 1988-1994. BMC Pulm Med (2014) 0.76
Associations between urinary soy isoflavonoids and two inflammatory markers in adults in the United States in 2005-2008. Cancer Causes Control (2013) 0.76
The adaptive neuroplasticity hypothesis of behavioral maintenance. Neural Plast (2012) 0.76
Elevated Baseline C-Reactive Protein as a Predictor of Outcome After Aneurysmal Subarachnoid Hemorrhage: Data From the Simvastatin in Aneurysmal Subarachnoid Hemorrhage (STASH) Trial. Neurosurgery (2015) 0.75
Ethnic/racial differences in the association between social support and levels of C-reactive proteins in the North Texas Heart Study. Psychophysiology (2016) 0.75
Evolution of lipid management guidelines: evidence might set you free. Can Fam Physician (2014) 0.75
Recommendations for lab-based screening tests for adult women. Adv Adm Lab (2014) 0.75
Genetics and women's health issues--the commitment of EMS to women scientists and gender-associated disease topics. Environ Mol Mutagen (2010) 0.75
Weight Gain Trajectories Associated With Elevated C-Reactive Protein Levels in Chinese Adults. J Am Heart Assoc (2016) 0.75
Comprehensive Review of the Impact of Dairy Foods and Dairy Fat on Cardiometabolic Risk. Adv Nutr (2016) 0.75
C-Reactive Protein Levels Among U.S. Adults Exposed to Parental Incarceration. Biol Res Nurs (2014) 0.75
Slower Decline in C-Reactive Protein after an Inflammatory Insult Is Associated with Longer Survival in Older Hospitalised Patients. PLoS One (2016) 0.75
Interactions between C-reactive protein genotypes with markers of nutritional status in relation to inflammation. Nutrients (2014) 0.75
Loneliness, Depression, and Inflammation: Evidence from the Multi-Ethnic Study of Atherosclerosis. PLoS One (2016) 0.75
The prevalence of cardiovascular disease risk factors and obesity in firefighters. J Obes (2012) 0.75
Plasma Macrophage Migration Inhibitor Factor Is Elevated in Response to Myocardial Ischemia. J Am Heart Assoc (2016) 0.75
Confounding in observational studies based on large health care databases: problems and potential solutions - a primer for the clinician. Clin Epidemiol (2017) 0.75
Significance of C-reactive protein and transcranial Doppler in cerebral vasospasm following aneurysmal subarachnoid hemorrhage. J Korean Neurosurg Soc (2013) 0.75
Risk Estimates for Atherosclerotic Cardiovascular Disease in Adults With Congenital Heart Disease. Am J Cardiol (2016) 0.75
Pretransplantation erythropoiesis-stimulating agent hyporesponsiveness is associated with increased kidney allograft failure and mortality. Transplantation (2013) 0.75
Ischaemic heart disease--a new issue in cystic fibrosis? J R Soc Med (2010) 0.75
Effect of body shape and inflammation on tooth loss in men and women. Clin Oral Investig (2016) 0.75
High-sensitive CRP as a predictive marker of long-term outcome in juvenile idiopathic arthritis. Rheumatol Int (2017) 0.75
High-sensitivity C reactive protein as a predictor of inhospital mortality in patients with cardiovascular disease at an emergency department: a retrospective cohort study. BMJ Open (2017) 0.75
Breast cancer screening: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med (2002) 12.65
GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol (2011) 10.02
Screening for prostate cancer: a review of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med (2011) 9.50
Risk prediction models for hospital readmission: a systematic review. JAMA (2011) 8.95
Screening for colorectal cancer: a targeted, updated systematic review for the U.S. Preventive Services Task Force. Ann Intern Med (2008) 7.26
Screening for lung cancer with low-dose computed tomography: a systematic review to update the US Preventive services task force recommendation. Ann Intern Med (2013) 7.19
Treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Systematic Review for a National Institutes of Health Pathways to Prevention Workshop. Ann Intern Med (2015) 5.12
Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: systematic evidence review for the U.S. Preventive Services Task Force. Ann Intern Med (2005) 4.66
Effectiveness and harms of recombinant human bone morphogenetic protein-2 in spine fusion: a systematic review and meta-analysis. Ann Intern Med (2013) 4.60
Nonhormonal therapies for menopausal hot flashes: systematic review and meta-analysis. JAMA (2006) 4.39
Screening for hepatocellular carcinoma in chronic liver disease: a systematic review. Ann Intern Med (2014) 4.34
Imaging strategies for low-back pain: systematic review and meta-analysis. Lancet (2009) 4.00
Comparative effectiveness of the C-MAC video laryngoscope versus direct laryngoscopy in the setting of the predicted difficult airway. Anesthesiology (2012) 3.94
Periodontal disease and coronary heart disease incidence: a systematic review and meta-analysis. J Gen Intern Med (2008) 3.54
Comparative efficacy and safety of long-acting oral opioids for chronic non-cancer pain: a systematic review. J Pain Symptom Manage (2003) 3.33
Screening for postmenopausal osteoporosis: a review of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med (2002) 3.06
GRADE guidelines: 7. Rating the quality of evidence--inconsistency. J Clin Epidemiol (2011) 3.02
Intensive insulin therapy in hospitalized patients: a systematic review. Ann Intern Med (2011) 2.94
Risk factors for breast cancer for women aged 40 to 49 years: a systematic review and meta-analysis. Ann Intern Med (2012) 2.85
Primary care-relevant interventions to prevent falling in older adults: a systematic evidence review for the U.S. Preventive Services Task Force. Ann Intern Med (2010) 2.84
GRADE guidelines: 8. Rating the quality of evidence--indirectness. J Clin Epidemiol (2011) 2.83
Homocysteine level and coronary heart disease incidence: a systematic review and meta-analysis. Mayo Clin Proc (2008) 2.83
Systematic review: comparative effectiveness of medications to reduce risk for primary breast cancer. Ann Intern Med (2009) 2.79
Challenges in synthesizing and interpreting the evidence from a systematic review of multifactorial interventions to prevent functional decline in older adults. J Am Geriatr Soc (2012) 2.77
Reporting discrepancies between the ClinicalTrials.gov results database and peer-reviewed publications. Ann Intern Med (2014) 2.67
AHRQ series paper 5: grading the strength of a body of evidence when comparing medical interventions--agency for healthcare research and quality and the effective health-care program. J Clin Epidemiol (2010) 2.63
Screening for hepatitis C virus infection: a review of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med (2004) 2.57
Emerging risk factors for coronary heart disease: a summary of systematic reviews conducted for the U.S. Preventive Services Task Force. Ann Intern Med (2009) 2.56
The cost-effectiveness of screening mammography beyond age 65 years: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med (2003) 2.31
Hyperbaric oxygen therapy for traumatic brain injury: a systematic review of the evidence. Arch Phys Med Rehabil (2004) 2.16
Racial and ethnic disparities in the VA health care system: a systematic review. J Gen Intern Med (2008) 2.11
Screening adults for type 2 diabetes: a review of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med (2008) 1.97
Systematic review of the incidence and consequences of uterine rupture in women with previous caesarean section. BMJ (2004) 1.94
Incorporating considerations of resources use into grading recommendations. BMJ (2008) 1.94
Challenges in systematic reviews that assess treatment harms. Ann Intern Med (2005) 1.82
Comparative effectiveness of antiviral treatment for hepatitis C virus infection in adults: a systematic review. Ann Intern Med (2012) 1.80
Screening for HIV: a review of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med (2005) 1.78
GRADE guidelines: 12. Preparing summary of findings tables-binary outcomes. J Clin Epidemiol (2012) 1.75
AHRQ series paper 3: identifying, selecting, and refining topics for comparative effectiveness systematic reviews: AHRQ and the effective health-care program. J Clin Epidemiol (2009) 1.73
The effectiveness of primary care-based interventions to promote breastfeeding: systematic evidence review and meta-analysis for the US Preventive Services Task Force. Ann Fam Med (2004) 1.72
Treatment of anemia in patients with heart disease: a systematic review. Ann Intern Med (2013) 1.61
Safety of vaginal birth after cesarean: a systematic review. Obstet Gynecol (2004) 1.58
Vaginal birth after cesarean: new insights on maternal and neonatal outcomes. Obstet Gynecol (2010) 1.57
Evidence on the benefits and harms of screening and treating pregnant women who are asymptomatic for bacterial vaginosis: an update review for the U.S. Preventive Services Task Force. Ann Intern Med (2008) 1.55
Can the emergency department algorithm detect changes in access to care? Acad Emerg Med (2008) 1.51
Screening for developmental dysplasia of the hip: a systematic literature review for the US Preventive Services Task Force. Pediatrics (2006) 1.51
Urinary Biomarkers for Diagnosis of Bladder Cancer: A Systematic Review and Meta-analysis. Ann Intern Med (2015) 1.50
An evaluation of statewide emergency department utilization following Tennessee Medicaid disenrollment. Acad Emerg Med (2011) 1.47
Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: a systematic review to update the U.S. Preventive Services Task Force recommendation. Ann Intern Med (2013) 1.46
Conflict of interest disclosures for clinical practice guidelines in the national guideline clearinghouse. PLoS One (2012) 1.43
Comparative efficacy and safety of skeletal muscle relaxants for spasticity and musculoskeletal conditions: a systematic review. J Pain Symptom Manage (2004) 1.41
Screening asymptomatic adults with resting or exercise electrocardiography: a review of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med (2011) 1.41
Impact of faculty-specific electronic reminders on faculty compliance with daily resident evaluations: a retrospective study. J Clin Anesth (2009) 1.37
Use of medications to reduce risk for primary breast cancer: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med (2013) 1.30
Community characteristics affecting emergency department use by Medicaid enrollees. Med Care (2009) 1.30
GRADE guidelines: 10. Considering resource use and rating the quality of economic evidence. J Clin Epidemiol (2012) 1.30
Author's specialty and conflicts of interest contribute to conflicting guidelines for screening mammography. J Clin Epidemiol (2012) 1.28
Screening and treatment for lipid disorders in children and adolescents: systematic evidence review for the US Preventive Services Task Force. Pediatrics (2007) 1.25
Diagnosis, access and outcomes: Update of a systematic review of telemedicine services. J Telemed Telecare (2006) 1.22
Prenatal screening for HIV: A review of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med (2005) 1.21
Improving the follow-up of positive hemoccult screening tests: an electronic intervention. J Gen Intern Med (2011) 1.21
Projected cost-effectiveness of statewide universal newborn hearing screening. Pediatrics (2002) 1.18
Racial disparities in renal replacement therapy. J Natl Med Assoc (2002) 1.15
Dosimetric evaluation of Acuros XB dose calculation algorithm with measurements in predicting doses beyond different air gap thickness for smaller and larger field sizes. J Med Phys (2013) 1.14
Impact of multiple cesarean deliveries on maternal morbidity: a systematic review. Am J Obstet Gynecol (2011) 1.13
A systematic review of the efficacy of telemedicine for making diagnostic and management decisions. J Telemed Telecare (2002) 1.12
Comparative benefits and harms of competing medications for adults with attention-deficit hyperactivity disorder: a systematic review and indirect comparison meta-analysis. Psychopharmacology (Berl) (2007) 1.12
High-resolution steady-state cerebral blood volume maps in patients with central nervous system neoplasms using ferumoxytol, a superparamagnetic iron oxide nanoparticle. J Cereb Blood Flow Metab (2013) 1.11
Perceived experiences of discrimination in health care: a barrier for cancer screening among American Indian women with type 2 diabetes. Womens Health Issues (2013) 1.09
Distances to emergency department and to primary care provider's office affect emergency department use in children. Acad Emerg Med (2009) 1.09
Attending and resident satisfaction with feedback in the emergency department. Acad Emerg Med (2009) 1.09
Risk ratios and odds ratios for common events in cross-sectional and cohort studies. Acad Emerg Med (2010) 1.05
Long-term cognitive function, neuroimaging, and quality of life in primary CNS lymphoma. Neurology (2013) 1.05
Telemedicine for the medicare population: update. Evid Rep Technol Assess (Full Rep) (2006) 1.04
Effect of an educational intervention on faculty and resident satisfaction with real-time feedback in the emergency department. Acad Emerg Med (2011) 1.04
Methodological shortcomings predicted lower harm estimates in one of two sets of studies of clinical interventions. J Clin Epidemiol (2006) 1.03
Comparative effectiveness research: challenges for medical journals. PLoS Med (2010) 1.03
Characteristics of physicians receiving large payments from pharmaceutical companies and the accuracy of their disclosures in publications: an observational study. BMC Med Ethics (2012) 1.03
Improving adherence to HIV quality of care indicators in persons with opioid dependence: the role of buprenorphine. J Acquir Immune Defic Syndr (2011) 1.02
Prevalence and reporting of occupational illness by company size: population trends and regulatory implications. Am J Ind Med (2004) 1.01
Imaging Techniques for the Diagnosis of Hepatocellular Carcinoma: A Systematic Review and Meta-analysis. Ann Intern Med (2015) 1.00
Hyperbaric oxygen therapy for stroke: a systematic review of the evidence. Clin Rehabil (2005) 0.99
Predictors of patient length of stay in 9 emergency departments. Am J Emerg Med (2012) 0.97
Training and career development for comparative effectiveness research workforce development: CTSA Consortium Strategic Goal Committee on comparative effectiveness research workgroup on workforce development. Clin Transl Sci (2010) 0.94
Cost-effectiveness of echocardiography to identify intracardiac thrombus among patients with first stroke or transient ischemic attack. Med Decis Making (2007) 0.94